无瘘管扩张的内镜超声引导胆管十二指肠吻合术使用管状哑铃形金属支架与内镜逆行胰胆管造影术在恶性远端胆道梗阻一线引流中的比较(附视频)
本研究纳入224例不可切除恶性远端胆道梗阻患者,经倾向性评分匹配后EUS-CDS组与ERCP组各71例。EUS-CDS组中位操作时间显著短于ERCP组(12分钟 vs 23分钟,P<.001),复发胆道梗阻发生率显著更低(13.0% vs 37.5%,P=.001),中位至复发胆道梗阻时间显著更长(不适用 vs 186天,P=.008)。结论认为无瘘管扩张EUS-CDS使用管状金属支架可能是此类患者一线引流的有效选择。
要点
- EUS-CDS组与ERCP组技术成功率分别为97.2%和90.1%,差异无统计学意义(P=.166)。
- 两组技术成功病例均获得临床成功。
- EUS-CDS组复发胆道梗阻发生率13.0%显著低于ERCP组37.5%(P=.001)。
核心结论
- 无瘘管扩张的EUS引导胆管十二指肠吻合术使用具有适当防移位功能的管状金属支架,可能是不可切除恶性远端胆道梗阻患者初始引流的有效选择。
研究设计与样本
- 研究纳入224例符合入选标准的不可切除恶性远端胆道梗阻患者,比较EUS-CDS组与行经乳头无覆膜金属支架置入的ERCP组的技术成功、临床成功、操作时间及不良事件(包括复发胆道梗阻),经一对一倾向性评分匹配后每组各71例。
主要发现
- EUS组与ERCP组技术成功率分别为97.2%和90.1%(P=.166)。
- 两组技术成功病例均获得临床成功。
- EUS组中位操作时间12分钟显著短于ERCP组23分钟(P<.001)。
- 除复发胆道梗阻外,两组早期和晚期不良事件发生率无显著差异。
- EUS组复发胆道梗阻发生率13.0%显著低于ERCP组37.5%(P=.001),中位至复发胆道梗阻时间显著更长(不适用 vs 186天,P=.008)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: EUS-guided choledochoduodenostomy (CDS) is a potential first-line drainage method for unresectable malignant distal biliary obstruction (UMDBO). However, lumen-apposing metal stents present difficulty in application for insufficient bile duct dilation, biliary wall compression, duodenobiliary reflux, and high cost. This study evaluated the utility of fistula dilation-free EUS-CDS with a tubular dumbbell-shaped metal stent (MS). METHODS: In total, 224 patients with UMDBO met the inclusion criteria. Technical and clinical success, procedure time, and adverse events (AEs) including recurrent biliary obstruction (RBO) were compared between the EUS-CDS group and ERCP group who underwent transpapillary uncovered MS placement. RESULTS: After one-to-one propensity score matching, 71 patients were included in each group. Technical success rates in the EUS and ERCP groups were 97.2% and 90.1%, respectively (P = .166). Clinical success was achieved in all technically successful cases in both groups. The median procedure time was significantly shorter in the EUS group than in the ERCP group (12 minutes vs 23 minutes, P < .001), whereas the rates of early and late AEs besides RBO were not significantly different between the groups. The EUS group demonstrated a significantly lower RBO incidence rate (13.0% vs 37.5%, respectively; P = .001) and significantly longer median time to RBO (not applicable vs 186 days, P = .008) compared with the ERCP group. Multivariate analysis revealed that EUS-CDS was associated with a significantly longer time to RBO. CONCLUSIONS: Fistula dilation-free EUS-CDS using tubular MS with an appropriate antimigration function may be a useful option for primary drainage in patients with UMDBO.
引用
- Inoue T, Kitano R, Kitada T, et al. Fistula dilation-free endoscopic ultrasound-guided choledochoduodenostomy using tubular dumbbell-shaped metal stent versus endoscopic retrograde cholangiopancreatography in first-line drainage for malignant distal biliary obstruction (with video). Gastrointest Endosc. 2025. PMID: 40449631. doi:10.1016/j.gie.2025.05.024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。